Skip to main content
Premium Trial:

Request an Annual Quote

MDS, Blending In Molecular Devices, Nearly Doubles Analytics Sales in Q3

NEW YORK (GenomeWeb News) — MDS today yesterday reported that third-quarter revenue for the segment comprising its MDS Sciex and Molecular Devices units increased 92 percent as organic receipts rose 11 percent and R&D spending doubled.
 
Total revenue for the three months ended July 31 increased to $127 million from $66 million for its MDS Analytical Technologies segment, which includes Sciex and Molecular Devices.
 
Molecular Devices contributed $55 million and the Sciex division added $72 million in revenue.
 
Much of the growth came from the Molecular Devices division, which MDS acquired in March, and the company said growth in its Sciex business was strong, particularly in the small-molecule business.  
  
MDS did not break out its balance sheet or segment earnings for the quarter.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.